Wang L - Search Results

1

Advances in Encapsulation and Delivery Strategies for Islet Transplantation.

Wu S, Wang L, Fang Y, Huang H, You X, Wu J. Wu S, et al. Among authors: wang l. Adv Healthc Mater. 2021 Oct;10(20):e2100965. doi: 10.1002/adhm.202100965. Epub 2021 Sep 3. Adv Healthc Mater. 2021. PMID: 34480420 Review.

2

Cysteine-based redox-responsive nanoparticles for small-molecule agent delivery.

Wang L, You X, Lou Q, He S, Zhang J, Dai C, Zhao M, Zhao M, Hu H, Wu J. Wang L, et al. Biomater Sci. 2019 Oct 1;7(10):4218-4229. doi: 10.1039/c9bm00907h. Epub 2019 Aug 7. Biomater Sci. 2019. PMID: 31389415

3

Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability.

Tong T , Wang L , You X , Wu J . Tong T , et al. Among authors: wang l. Biomater Sci. 2020 Nov 7;8(21):5804-5823. doi: 10.1039/d0bm01151g. Epub 2020 Oct 5. Biomater Sci. 2020. PMID: 33016274 Review.

4

Hemostatic nanotechnologies for external and internal hemorrhage management.

Wang L , You X , Dai C , Tong T , Wu J . Wang L , et al. Biomater Sci. 2020 Aug 21;8(16):4396-4412. doi: 10.1039/d0bm00781a. Epub 2020 Jul 13. Biomater Sci. 2020. PMID: 32658944 Review.

5

Development of poly(p-coumaric acid) as a self-anticancer nanocarrier for efficient and biosafe cancer therapy.

Wang L, You X, Dai C, Fang Y, Wu J. Wang L, et al. Biomater Sci. 2022 May 4;10(9):2263-2274. doi: 10.1039/d2bm00027j. Biomater Sci. 2022. PMID: 35362499

6

Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives.

Zhang J, Wang L, You X, Xian T, Wu J, Pang J. Zhang J, et al. Among authors: wang l. Curr Top Med Chem. 2019;19(1):57-73. doi: 10.2174/1568026619666190125145836. Curr Top Med Chem. 2019. PMID: 30686255 Review.

7

Overcoming therapeutic failure in osteosarcoma via Apatinib-encapsulated hydrophobic poly(ester amide) nanoparticles.

Li X, Wang L, Wang L, Yu J, Lu G, Zhao W, Miao C, Zou C, Wu J. Li X, et al. Among authors: wang l. Biomater Sci. 2020 Oct 27;8(21):5888-5899. doi: 10.1039/d0bm01296c. Biomater Sci. 2020. PMID: 33001086

8

Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional Addiction.

Huang CS, Xu QC, Dai C, Wang L, Tien YC, Li F, Su Q, Huang XT, Wu J, Zhao W, Yin XY. Huang CS, et al. Among authors: wang l. ACS Nano. 2021 Sep 28;15(9):14744-14755. doi: 10.1021/acsnano.1c04570. Epub 2021 Aug 18. ACS Nano. 2021. PMID: 34405985

9

Histone methyltransferase G9a inhibitor-loaded redox-responsive nanoparticles for pancreatic ductal adenocarcinoma therapy.

Wang JQ , Wang LY , Li SJ , Tong T , Wang L , Huang CS , Xu QC , Huang XT , Li JH , Wu J , Zhao W , Yin XY . Wang JQ , et al. Among authors: wang ly, wang l. Nanoscale. 2020 Aug 7;12(29):15767-15774. doi: 10.1039/d0nr03138k. Epub 2020 Jul 20. Nanoscale. 2020. PMID: 32729861

10

Biotherapeutic Nanoparticles of Poly(Ferulic Acid) Delivering Doxorubicin for Cancer Therapy.

Zheng Y, You X, Chen L, Huang J, Wang L, Wu J, Guan S. Zheng Y, et al. Among authors: wang l. J Biomed Nanotechnol. 2019 Aug 1;15(8):1734-1743. doi: 10.1166/jbn.2019.2798. J Biomed Nanotechnol. 2019. PMID: 31219014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,035 results

Search Page

Filters